Dr. Felix Strand

The Brief

Dr. Felix Strand was fifty-three when the Dimming reached him. He had spent years at the Zephyria Free University's Consciousness Research Institute documenting below-baseline degradation — the neurological damage that follows augmentation removal. The research required Professional-tier augmentation to conduct. The university's grant funded the licensing. When Nexus Dynamics applied sufficient political pressure to Zephyria's funding bodies, 75% of the Institute's budget evaporated and the grant ended.

Strand took a Prosperity Pathway loan to maintain the augmentation he needed to continue the work. The loan defaulted. He was dimmed by the same mechanism he had spent years documenting. His clinical notes — written during the degradation, growing simpler with each entry as his processing capacity contracted — became the primary medical evidence for the condition he'd been trying to expose.

Before the Institute, he had been a Helix Biotech pharmaceutical assistant, deprecated in 2182 when Helix restructured its research division. He chose the Dregs over firmware reversion then. The reversion found him anyway through the defaulted loan. What survived was the pharmaceutical knowledge acquired before augmentation — stored in the part of his brain the rollback procedure couldn't touch. He is slower than he was. In the Heat Ward, he is still faster than anyone else available.

Field Observations

Those who work alongside him in the Heat Ward note that he measures things he cannot stop measuring. Patient intake, treatment outcomes, the date and time of each intervention. He keeps a physical count — 847 as of February 2184. He records it the way you record something that matters, though he will tell you the number is meaningless.

His handwriting in the clinical notes changes over the weeks of documented degradation. Early entries: precise, compressed, researcher's shorthand. Later entries: larger characters, harder pen pressure, as if he believed force could substitute for dexterity. The progression is legible as a measurement of loss even to someone who doesn't read the content.

He applied to the Insomnia Wards three times. Not for sleep treatment. He wants a room where diminishment is the design condition — where dim is the aesthetic, not the punishment. Each application was denied on the grounds that his symptoms don't meet the clinical threshold. He is, technically, functional. This appears to be the part that bothers him.

His own summary of the condition, from the final legible entry of his research notes: "I am a library with a reading room too small for the books. The books are all mine. I wrote them. I cannot read them."

What the Notes Say

Strand's clinical records circulate through G Nook terminals in the Dregs. They are the only first-person medical account of below-baseline degradation written by a trained neurologist during the event itself. Corporate medicine has produced no equivalent — the condition is not acknowledged in any licensed medical system.

The notes contain one observation that researchers have found difficult to dismiss: degradation severity correlates not with augmentation level but with augmentation churn. A stable enhancement, fully integrated over time, causes less damage on removal than an unstable enhancement cycling through mandatory updates. Strand calculated this from his own case and from interviews with seventeen other dimmed individuals he conducted during his deterioration. The thirty-seven-day update cycle that Nexus and others impose for licensing compliance was designed for revenue. His data suggests it was also optimized, incidentally, for maximizing neurological damage on removal.

He has not claimed this was intentional. He has only published the correlation.